|
Insider Trading: SAVIENT PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of SAVIENT PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of SAVIENT PHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of SAVIENT PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is SVNT.
The reporting company's CIK number is 722104.
The total value of stock buying since 2005 is $402,239.
The total value of stock sales is $10,311,199.
The total value of stock exercises is $1,450,451.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at SAVIENT PHARMACEUTICALS INC (SVNT) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at SAVIENT PHARMACEUTICALS INC (SVNT) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for SAVIENT PHARMACEUTICALS INC (SVNT).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-06 | 0 | 0 | 12,159 | 313,706 | 15,659 | 149,288 |
| 2008-05 | 0 | 0 | 18,232 | 434,998 | 0 | 0 |
| 2008-04 | 0 | 0 | 25,140 | 503,336 | 10,000 | 31,550 |
| 2008-03 | 0 | 0 | 12,375 | 283,002 | 12,375 | 77,061 |
| 2008-02 | 0 | 0 | 55,693 | 1,136,593 | 22,375 | 99,760 |
| 2008-01 | 0 | 0 | 172,545 | 3,888,771 | 149,375 | 431,946 |
| 2007-12 | 0 | 0 | 78,103 | 1,357,533 | 48,333 | 238,331 |
| 2007-11 | 0 | 0 | 10,000 | 141,357 | 10,000 | 125,082 |
| 2007-10 | 0 | 0 | 45,855 | 707,602 | 45,855 | 297,433 |
| 2007-05 | 0 | 0 | 1,220 | 17,505 | 0 | 0 |
| 2007-04 | 0 | 0 | 15,218 | 182,910 | 0 | 0 |
| 2007-03 | 0 | 0 | 78,504 | 985,095 | 0 | 0 |
| 2007-02 | 0 | 0 | 13,192 | 190,903 | 0 | 0 |
| 2007-01 | 0 | 0 | 2,096 | 31,389 | 0 | 0 |
| 2006-12 | 0 | 0 | 900 | 10,512 | 0 | 0 |
| 2006-09 | 6,000 | 38,394 | 0 | 0 | 0 | 0 |
| 2006-08 | 6,000 | 35,010 | 0 | 0 | 0 | 0 |
| 2006-07 | 6,000 | 31,590 | 0 | 0 | 0 | 0 |
| 2006-06 | 3,000 | 17,502 | 0 | 0 | 0 | 0 |
| 2006-05 | 10,000 | 54,917 | 0 | 0 | 0 | 0 |
| 2006-04 | 0 | 0 | 21,464 | 125,987 | 0 | 0 |
| 2005-06 | 11,800 | 39,371 | 0 | 0 | 0 | 0 |
| 2005-05 | 60,000 | 185,455 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for SAVIENT PHARMACEUTICALS INC (SVNT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-06-24 | Hamelin Paul (SVP, Commercial Operations) | Sale | 1,231 | 25.25 | 31,082 |
| 2008-06-24 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 1,231 | 5.11 | 6,290 |
| 2008-06-23 | Hamelin Paul (SVP, Commercial Operations) | Sale | 5,000 | 25.75 | 128,751 |
| 2008-06-23 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 5,000 | 12.11 | 60,550 |
| 2008-06-19 | Hamelin Paul (SVP, Commercial Operations) | Sale | 1,928 | 24.89 | 47,993 |
| 2008-06-19 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 1,928 | 12.11 | 23,348 |
| 2008-06-03 | Thompson Virgil (Director) | Option Exercise | 7,500 | 7.88 | 59,100 |
| 2008-06-02 | Klein Joseph Iii (Director) | Sale | 4,000 | 26.47 | 105,880 |
| 2008-05-27 | Klein Joseph Iii (Director) | Sale | 4,000 | 24.07 | 96,280 |
| 2008-05-23 | Hamelin Paul (SVP, Commercial Operations) | Sale | 1,232 | 24.09 | 29,678 |
| 2008-05-19 | Klein Joseph Iii (Director) | Sale | 4,000 | 22.67 | 90,680 |
| 2008-05-12 | Klein Joseph Iii (Director) | Sale | 4,000 | 24.59 | 98,360 |
| 2008-05-06 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 24.00 | 120,000 |
| 2008-04-14 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 3,785 | 19.00 | 71,919 |
| 2008-04-14 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 3,785 | 19.05 | 72,094 |
| 2008-04-14 | Clement Christopher G (President & CEO) | Sale | 7,570 | 19.06 | 144,303 |
| 2008-04-02 | Conrad Herbert J (Director) | Sale | 5,000 | 21.11 | 105,572 |
| 2008-04-02 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 2.48 | 12,400 |
| 2008-04-01 | Conrad Herbert J (Director) | Sale | 5,000 | 21.89 | 109,448 |
| 2008-04-01 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 3.83 | 19,150 |
| 2008-03-04 | Conrad Herbert J (Director) | Sale | 5,000 | 23.00 | 115,000 |
| 2008-03-04 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 4.61 | 23,050 |
| 2008-03-03 | Hamelin Paul (SVP, Commercial Operations) | Sale | 2,375 | 22.78 | 54,102 |
| 2008-03-03 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 2,375 | 12.11 | 28,761 |
| 2008-03-03 | Conrad Herbert J (Director) | Sale | 5,000 | 22.78 | 113,900 |
| 2008-03-03 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 5.05 | 25,250 |
| 2008-02-29 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 2,279 | 24.00 | 54,696 |
| 2008-02-28 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 24.06 | 120,295 |
| 2008-02-20 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 2,455 | 20.01 | 49,113 |
| 2008-02-15 | Hamelin Paul (SVP, Commercial Operations) | Sale | 1,636 | 19.92 | 32,587 |
| 2008-02-15 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 1,255 | 20.08 | 25,195 |
| 2008-02-15 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 2,817 | 19.98 | 56,279 |
| 2008-02-15 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 2,361 | 20.01 | 47,232 |
| 2008-02-15 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 4,403 | 19.95 | 87,844 |
| 2008-02-15 | Clement Christopher G (President & CEO) | Sale | 11,112 | 20.00 | 222,240 |
| 2008-02-04 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 19.86 | 99,306 |
| 2008-02-04 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 4.31 | 21,549 |
| 2008-02-04 | Conrad Herbert J (Director) | Sale | 5,000 | 20.00 | 100,000 |
| 2008-02-04 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2008-02-01 | Hamelin Paul (SVP, Commercial Operations) | Sale | 2,375 | 20.00 | 47,500 |
| 2008-02-01 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 2,375 | 12.11 | 28,761 |
| 2008-02-01 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 19.56 | 97,791 |
| 2008-02-01 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-02-01 | Conrad Herbert J (Director) | Sale | 5,000 | 19.30 | 96,515 |
| 2008-02-01 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 2.70 | 13,500 |
| 2008-01-22 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 20.21 | 101,061 |
| 2008-01-22 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-18 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 20.67 | 103,336 |
| 2008-01-18 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-17 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 20.44 | 102,198 |
| 2008-01-17 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-17 | Clement Christopher G (President & CEO) | Sale | 5,000 | 20.29 | 101,450 |
| 2008-01-17 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.97 | 14,850 |
| 2008-01-16 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 20.64 | 103,218 |
| 2008-01-16 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-16 | Clement Christopher G (President & CEO) | Sale | 5,000 | 21.24 | 106,199 |
| 2008-01-16 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.97 | 14,850 |
| 2008-01-15 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 21.46 | 107,302 |
| 2008-01-15 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-15 | Clement Christopher G (President & CEO) | Sale | 5,000 | 21.36 | 106,799 |
| 2008-01-15 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.88 | 14,375 |
| 2008-01-14 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 21.77 | 108,845 |
| 2008-01-14 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-14 | Clement Christopher G (President & CEO) | Sale | 5,000 | 21.64 | 108,200 |
| 2008-01-14 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.78 | 13,899 |
| 2008-01-11 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 22.02 | 110,079 |
| 2008-01-11 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-11 | Clement Christopher G (President & CEO) | Sale | 5,000 | 22.00 | 109,997 |
| 2008-01-11 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.78 | 13,899 |
| 2008-01-10 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 21.93 | 109,652 |
| 2008-01-10 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-10 | Clement Christopher G (President & CEO) | Sale | 5,000 | 22.42 | 112,100 |
| 2008-01-10 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.78 | 13,899 |
| 2008-01-09 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 21.59 | 107,967 |
| 2008-01-09 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-09 | Clement Christopher G (President & CEO) | Sale | 5,000 | 21.88 | 109,411 |
| 2008-01-09 | Clement Christopher G (President & CEO) | Option Exercise | 5,000 | 2.78 | 13,899 |
| 2008-01-08 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 5,000 | 23.15 | 115,759 |
| 2008-01-08 | Yachmetz Philip K (EVP, Chief Business Officer) | Option Exercise | 5,000 | 2.42 | 12,100 |
| 2008-01-08 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 23.15 | 115,727 |
| 2008-01-08 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-08 | Clement Christopher G (President & CEO) | Sale | 5,170 | 23.15 | 119,692 |
| 2008-01-08 | Clement Christopher G (President & CEO) | Option Exercise | 2,000 | 2.78 | 5,560 |
| 2008-01-07 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 5,000 | 23.02 | 115,105 |
| 2008-01-07 | Yachmetz Philip K (EVP, Chief Business Officer) | Option Exercise | 5,000 | 2.60 | 13,000 |
| 2008-01-07 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 23.00 | 115,025 |
| 2008-01-07 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-07 | Clement Christopher G (President & CEO) | Sale | 5,000 | 23.00 | 115,000 |
| 2008-01-04 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 5,000 | 23.27 | 116,331 |
| 2008-01-04 | Yachmetz Philip K (EVP, Chief Business Officer) | Option Exercise | 5,000 | 2.78 | 13,899 |
| 2008-01-04 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 23.26 | 116,320 |
| 2008-01-04 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-03 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 24.26 | 121,286 |
| 2008-01-03 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 5,000 | 24.26 | 121,286 |
| 2008-01-03 | Yachmetz Philip K (EVP, Chief Business Officer) | Option Exercise | 5,000 | 2.60 | 13,000 |
| 2008-01-03 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 24.25 | 121,226 |
| 2008-01-03 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-03 | Conrad Herbert J (Director) | Sale | 5,000 | 24.24 | 121,199 |
| 2008-01-03 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 3.20 | 16,005 |
| 2008-01-03 | Clement Christopher G (President & CEO) | Sale | 5,000 | 24.23 | 121,161 |
| 2008-01-02 | Hamelin Paul (SVP, Commercial Operations) | Sale | 2,375 | 23.60 | 56,050 |
| 2008-01-02 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 2,375 | 12.11 | 28,761 |
| 2008-01-02 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 23.47 | 117,360 |
| 2008-01-02 | Hayden Brian J (SVP, Chief Financial Officer) | Option Exercise | 5,000 | 5.33 | 26,650 |
| 2008-01-02 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 5,000 | 23.47 | 117,330 |
| 2008-01-02 | Yachmetz Philip K (EVP, Chief Business Officer) | Option Exercise | 5,000 | 2.42 | 12,100 |
| 2008-01-02 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 5,000 | 23.47 | 117,340 |
| 2008-01-02 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Option Exercise | 5,000 | 2.52 | 12,600 |
| 2008-01-02 | Conrad Herbert J (Director) | Sale | 5,000 | 23.60 | 118,000 |
| 2008-01-02 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 2.96 | 14,800 |
| 2008-01-02 | Clement Christopher G (President & CEO) | Sale | 5,000 | 23.95 | 119,760 |
| 2007-12-19 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 20.75 | 103,749 |
| 2007-12-19 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 3.82 | 19,100 |
| 2007-12-18 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 20.10 | 100,519 |
| 2007-12-18 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2007-12-18 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 20.09 | 100,440 |
| 2007-12-18 | Hayden Brian J (SVP, Chief Financial Officer) | Option Exercise | 5,000 | 5.33 | 26,650 |
| 2007-12-17 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 19.91 | 99,537 |
| 2007-12-17 | Hayden Brian J (SVP, Chief Financial Officer) | Option Exercise | 5,000 | 5.33 | 26,650 |
| 2007-12-14 | Hamelin Paul (SVP, Commercial Operations) | Sale | 3,333 | 17.12 | 57,058 |
| 2007-12-14 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 3,333 | 5.11 | 17,031 |
| 2007-12-14 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 18.49 | 92,427 |
| 2007-12-14 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2007-12-14 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 17.12 | 85,596 |
| 2007-12-14 | Hayden Brian J (SVP, Chief Financial Officer) | Option Exercise | 5,000 | 5.33 | 26,650 |
| 2007-12-13 | Hamelin Paul (SVP, Commercial Operations) | Sale | 5,000 | 17.74 | 88,720 |
| 2007-12-13 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 5,000 | 5.11 | 25,550 |
| 2007-12-13 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 17.84 | 89,200 |
| 2007-12-13 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2007-12-13 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 5,000 | 17.18 | 85,893 |
| 2007-12-13 | Hayden Brian J (SVP, Chief Financial Officer) | Option Exercise | 5,000 | 5.33 | 26,650 |
| 2007-12-10 | Hamelin Paul (SVP, Commercial Operations) | Sale | 2,353 | 15.22 | 35,819 |
| 2007-12-10 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 2,368 | 15.32 | 36,287 |
| 2007-12-10 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 7,774 | 15.22 | 118,344 |
| 2007-12-10 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 6,046 | 15.31 | 92,588 |
| 2007-12-10 | Clement Christopher G (President & CEO) | Sale | 11,229 | 15.26 | 171,356 |
| 2007-11-30 | Conrad Herbert J (Director) | Sale | 5,000 | 14.03 | 70,132 |
| 2007-11-30 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 12.74 | 63,700 |
| 2007-11-29 | Conrad Herbert J (Director) | Sale | 2,500 | 14.74 | 36,850 |
| 2007-11-29 | Conrad Herbert J (Director) | Option Exercise | 2,500 | 12.74 | 31,850 |
| 2007-11-28 | Conrad Herbert J (Director) | Sale | 2,500 | 13.75 | 34,375 |
| 2007-11-28 | Conrad Herbert J (Director) | Option Exercise | 2,500 | 11.81 | 29,532 |
| 2007-10-16 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 2,600 | 15.52 | 40,352 |
| 2007-10-16 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 2,600 | 4.67 | 12,142 |
| 2007-10-15 | Hamelin Paul (SVP, Commercial Operations) | Sale | 1,667 | 15.52 | 25,871 |
| 2007-10-15 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 1,667 | 5.11 | 8,518 |
| 2007-10-15 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 15.52 | 77,600 |
| 2007-10-15 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2007-10-10 | Conrad Herbert J (Director) | Sale | 5,000 | 15.11 | 75,550 |
| 2007-10-10 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 11.81 | 59,065 |
| 2007-10-09 | Conrad Herbert J (Director) | Sale | 5,000 | 15.12 | 75,585 |
| 2007-10-09 | Conrad Herbert J (Director) | Option Exercise | 5,000 | 7.41 | 37,030 |
| 2007-10-08 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 15.52 | 77,600 |
| 2007-10-08 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2007-10-08 | Conrad Herbert J (Director) | Sale | 4,629 | 15.52 | 71,842 |
| 2007-10-08 | Conrad Herbert J (Director) | Option Exercise | 4,629 | 7.64 | 35,367 |
| 2007-10-05 | Hamelin Paul (SVP, Commercial Operations) | Sale | 2,500 | 15.52 | 38,800 |
| 2007-10-05 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 2,500 | 5.11 | 12,775 |
| 2007-10-05 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 1,588 | 15.52 | 24,645 |
| 2007-10-05 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 1,588 | 4.67 | 7,415 |
| 2007-10-05 | Conrad Herbert J (Director) | Sale | 2,871 | 15.52 | 44,557 |
| 2007-10-05 | Conrad Herbert J (Director) | Option Exercise | 2,871 | 7.88 | 22,609 |
| 2007-10-03 | Hamelin Paul (SVP, Commercial Operations) | Sale | 2,500 | 15.52 | 38,800 |
| 2007-10-03 | Hamelin Paul (SVP, Commercial Operations) | Option Exercise | 2,500 | 5.11 | 12,775 |
| 2007-10-03 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 5,000 | 15.52 | 77,600 |
| 2007-10-03 | Lamm Robert (SVP, Quality & Reg Affairs) | Option Exercise | 5,000 | 4.67 | 23,350 |
| 2007-10-03 | Conrad Herbert J (Director) | Sale | 2,500 | 15.52 | 38,800 |
| 2007-10-03 | Conrad Herbert J (Director) | Option Exercise | 2,500 | 7.88 | 19,687 |
| 2007-05-23 | Hamelin Paul (SVP, Commercial Operations) | Sale | 1,220 | 14.35 | 17,505 |
| 2007-04-12 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 3,805 | 12.06 | 45,903 |
| 2007-04-12 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 3,805 | 12.01 | 45,707 |
| 2007-04-12 | Clement Christopher G (President & CEO) | Sale | 7,608 | 12.00 | 91,300 |
| 2007-03-05 | Hayden Brian J (SVP, Chief Financial Officer) | Sale | 4,450 | 12.52 | 55,714 |
| 2007-03-05 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 20,881 | 12.53 | 261,638 |
| 2007-03-05 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 18,942 | 12.50 | 236,775 |
| 2007-03-05 | Clement Christopher G (President & CEO) | Sale | 34,231 | 12.59 | 430,968 |
| 2007-02-15 | Yachmetz Philip K (EVP, Chief Business Officer) | Sale | 3,051 | 14.44 | 44,045 |
| 2007-02-15 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 2,517 | 14.47 | 36,411 |
| 2007-02-15 | Clement Christopher G (President & CEO) | Sale | 7,624 | 14.49 | 110,447 |
| 2007-01-22 | Lamm Robert (SVP, Quality & Reg Affairs) | Sale | 2,096 | 14.98 | 31,389 |
| 2006-12-04 | Tendler David (Director) | Sale | 900 | 11.68 | 10,512 |
| 2006-09-15 | Klein Joseph Iii (Director) | Purchase | 3,000 | 6.30 | 18,900 |
| 2006-09-01 | Klein Joseph Iii (Director) | Purchase | 3,000 | 6.50 | 19,494 |
| 2006-08-15 | Klein Joseph Iii (Director) | Purchase | 3,000 | 5.79 | 17,370 |
| 2006-08-01 | Klein Joseph Iii (Director) | Purchase | 3,000 | 5.88 | 17,640 |
| 2006-07-18 | Klein Joseph Iii (Director) | Purchase | 3,000 | 5.19 | 15,570 |
| 2006-07-03 | Klein Joseph Iii (Director) | Purchase | 3,000 | 5.34 | 16,020 |
| 2006-06-01 | Klein Joseph Iii (Director) | Purchase | 3,000 | 5.83 | 17,502 |
| 2006-05-25 | Heller Alan L (Director) | Purchase | 10,000 | 5.49 | 54,917 |
| 2006-04-12 | Yachmetz Philip K (SVP, General Counsel) | Sale | 4,992 | 5.87 | 29,297 |
| 2006-04-12 | Horowitz Zebulun D (SVP, Chief Medical Officer) | Sale | 6,159 | 5.87 | 36,153 |
| 2006-04-12 | Clement Christopher G (President & CEO) | Sale | 10,313 | 5.87 | 60,537 |
| 2005-06-13 | Weissbach Herbert (Director) | Purchase | 4,300 | 3.47 | 14,921 |
| 2005-06-07 | Hayward Surry Jeremy (Director) | Purchase | 7,500 | 3.26 | 24,450 |
| 2005-05-18 | Yachmetz Philip K (SVP, General Counsel) | Purchase | 10,000 | 3.18 | 31,780 |
| 2005-05-18 | Clement Christopher G (CEO) | Purchase | 15,000 | 3.09 | 46,350 |
| 2005-05-17 | Fink David L (SVP, Commercial Oper) | Purchase | 20,000 | 3.06 | 61,200 |
| 2005-05-17 | Gyenes Lawrence A (SVP, Chief Financial) | Purchase | 15,000 | 3.08 | 46,125 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of SAVIENT PHARMACEUTICALS INC (symbol SVNT,
CIK number 722104) see
the Securities and Exchange Commission (SEC) website.
|
|
